Pfizer CEO: On Track to Give U.S. 120M Doses by End of March

The transcript outlines efforts to expand global production capabilities, including new formulation suites and production sites in Kalamazoo, Groton, and McPherson. It highlights process improvements that have doubled batch sizes and increased yield, reducing production timelines from 110 to 60 days. Thanks to these efforts and support from the Biden administration, the company plans to increase dose shipments from 5 million to over 10 million per week, aiming to deliver 120 million doses by March and 200 million by May.

What role did the Biden administration play in the production improvements?

What is the target number of doses to be released by the end of May?